Our Co-Founder Lars Steinmetz speaks at Precision Medicine World Conference (PMWC) Virtual COVID-19 Edition on how using precision health data can bring surface insights and create value for different industry players – pharma, diagnostic companies, providers, and technology companies.

The panel discussion was led by Lee Hood, Senior Vice President and Chief Strategy Officer for the Institute for Systems Biology and Senior Vice President and Chief Science Office for Providence St. Joseph Health, joined by Ida Grundberg, CSO of Olink Proteomics, and Kevin Hrusovsky, CEO and President at Quanterix.

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support@sophiagenetics.com to obtain the appropriate product information for your country of residence.